Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
07/2012
07/24/2012US8226947 Interleukin-10 antibodies
07/24/2012US8226946 Enhancement of light activated therapy by immune augmentation using anti-CTLA-4 antibody
07/24/2012US8226945 Antibodies and immunoconjugates and uses therefor
07/24/2012US8226944 Composition for treating virus infection disease comprising Jab1
07/24/2012US8226943 Antibodies to notch receptors
07/24/2012US8226937 Agents for promoting IgA production
07/24/2012US8226935 ErbB2 and ErbB3 chimeric heteromultimer receptors
07/24/2012US8226611 Anti-IL-6 antibodies, compositions, methods and uses
07/24/2012CA2566687C The use of tiacumicin b in the treatment of antibiotic resistant staphylococcus or vancomycin-resistant enterococci infections
07/24/2012CA2486252C Methods for screening for agents that modulate hepatocellular carcinoma development
07/24/2012CA2342289C Treatment of cervical cancer
07/19/2012WO2012097346A1 Compositions and methods for treating viral infections
07/19/2012WO2012097333A2 Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
07/19/2012WO2012097288A1 Human antibodies that bind the p40 subunit of human il-12/il-23 and uses therefor
07/19/2012WO2012097238A2 Il-27 antagonists for treating inflammatory diseases
07/19/2012WO2012097185A2 Omv vaccine against burkholderia infections
07/19/2012WO2012097160A1 Rectal delivery method for therapeutic peptides
07/19/2012WO2012097062A1 Methods for treating or preventing cardiac and neurological disorders using chemokine receptor antagonists
07/19/2012WO2012097049A2 Dna repair enzyme inhibitor nanoparticles and uses thereof
07/19/2012WO2012096999A1 Infectious hepatitis e virus genotype 3 recombinants
07/19/2012WO2012096994A2 Antibodies directed against influenza
07/19/2012WO2012096974A1 Enhancement of allogeneic hematopoietic stem cell transplantation
07/19/2012WO2012096960A2 Stem cell factor inhibitor
07/19/2012WO2012096924A1 Novel uses
07/19/2012WO2012096917A1 Anti-tlr4 antibodies and methods of use thereof
07/19/2012WO2012096862A1 Vaccination of cancer patients
07/19/2012WO2012095789A1 Pharmaceutical composition for treating cancer
07/19/2012WO2012095432A2 Tlr3 binding agents
07/19/2012WO2012095412A1 Combination therapy including tumor associated antigen binding antibodies
07/19/2012WO2012067866A3 Multivalent vaccine for filariasis
07/19/2012WO2012067483A3 Newcastle disease virus and the use thereof as a vaccine
07/19/2012WO2012065105A3 Chimeric flavivirus vaccines
07/19/2012WO2012064834A3 Methods for organ regeneration
07/19/2012WO2012064760A3 Materials and methods for directing an immune response to an epitope
07/19/2012WO2012064627A3 Subcutaneously administered anti-il-6 receptor antibody
07/19/2012WO2012060678A3 Novel vaccines against the a/h1n1 pandemic flu virus
07/19/2012WO2012059857A3 Pan-her antibody composition
07/19/2012WO2012058492A3 Viral vaccine and process for preparing the same
07/19/2012WO2012058418A3 Compositions targeting the soluble extracellular domain of e-cadherin and related methods for cancer therapy
07/19/2012WO2012047267A3 Polyvalent immunogen
07/19/2012WO2012040806A3 Synergistic immunogenic compositions based on protein antigens combined with pertussis cell antigen and inactivated toxins
07/19/2012WO2012040474A3 Recombinant viral vectors and methods for inducing an immune response to yellow fever virus
07/19/2012WO2012040266A3 Gene-based adjuvants and compositions thereof to increase antibody production in response to gene-based vaccines
07/19/2012WO2012036870A3 Monoclonal antibodies and detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid
07/19/2012WO2012034077A3 Compositions and methods related to attenuated staphylococcal strains
07/19/2012WO2012027570A4 Dual variable domain immunoglobulins and uses thereof
07/19/2012WO2012021786A3 Anti-hemagglutinin antibody compositions and methods of use thereof
07/19/2012WO2012019061A3 Novel effectors and methods of use
07/19/2012WO2012017310A3 Protein fusion constructs possessing thrombolytic and anticoagulant properties
07/19/2012WO2012009447A3 THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF
07/19/2012WO2011163628A3 Dengue virus (dv) polypeptide sequences, t cell epitopes and methods and uses thereof
07/19/2012WO2011160078A3 Use of camelid-derived variable heavy chain variable regions targeting cd18 and icam-1 as a microbicide to prevent hiv-1 transmission
07/19/2012WO2011133687A3 Methods and compositions for inhibition of beta2-adrenergic receptor degradation
07/19/2012WO2011130434A9 Antibodies that bind human cd27 and uses thereof
07/19/2012WO2011038473A8 Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of dna and chimeric virus vaccines
07/19/2012US20120184485 Uses of cystatin
07/19/2012US20120183599 Pharmaceutical Composition
07/19/2012US20120183598 Hla-a2 tumor associated antigen peptides and compositions
07/19/2012US20120183597 Method of inducing neutralizing antibodies to human immunodeficiency virus
07/19/2012US20120183595 Transdermal Pharmaceutical Delivery Composition
07/19/2012US20120183593 Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
07/19/2012US20120183578 Polyethylene glycol-based dendrons
07/19/2012US20120183577 Compositions useful as inhibitors of protein kinases
07/19/2012US20120183576 Modified gram-negative bacteria for use as vaccines
07/19/2012US20120183575 Exosome based treatment of cancer
07/19/2012US20120183574 Modified vaccinia virus ankara for the vaccnation of neonates
07/19/2012US20120183573 Intracellular viral vector delivery method employing iron ion/viral vector composite
07/19/2012US20120183570 Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions
07/19/2012US20120183569 Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
07/19/2012US20120183568 Bioassay for the early detection of autoimmune diseases
07/19/2012US20120183567 Process for producing water-soluble hyaluronic acid modification
07/19/2012US20120183566 Aldehyde-Tagged Immunoglobulin Polypeptides and Methods of Use Thereof
07/19/2012US20120183565 Fully human antibodies to btla
07/19/2012US20120183564 Inhibition of endosomal toll-like receptor activation
07/19/2012US20120183563 Iminothiadiazine dioxide compounds as bace inhibitors, compositions and their use
07/19/2012US20120183562 Secreted fxyd proteins expressed in response to epithelial tissue damage, and uses therefor
07/19/2012US20120183561 Alpha-4-beta-7 heterodimer specific antagonist antibody
07/19/2012US20120183560 Monoclonal Antibodies
07/19/2012US20120183559 Novel anti-igf-ir antibodies and uses thereof
07/19/2012US20120183558 Antibody molecules which bind il-17a and il-17f
07/19/2012US20120183557 Hiv tat-cd4 hybrid molecules and methods of use thereof
07/19/2012US20120183556 Suppressant for atherosclerosis
07/19/2012US20120183555 Serum markers associated with early and other stages of breast cancer
07/19/2012US20120183554 Biomarker
07/19/2012US20120183553 Treatment and diagnosis of immune disorders
07/19/2012US20120183552 Kidney disease targets and uses thereof
07/19/2012US20120183551 Novel human p53 splice variant displaying differential transcriptional activity
07/19/2012US20120183550 Therapeutic Using a Bispecific Antibody
07/19/2012US20120183549 Chemokine receptor binding polypeptides
07/19/2012US20120183548 IL-27 Antagonists for Treating Inflammatory Diseases
07/19/2012US20120183547 Compositions and methods comprising vegfr-2 and vegfr-3 antagonists for the treatment of metastatic disease
07/19/2012US20120183546 Treatment of ovarian cancer using a specific binding agent of human angiopoietin-2 in combination with a taxane
07/19/2012US20120183545 CD20-Binding Polypeptide Compositions and Methods
07/19/2012US20120183544 Diagnosis and treatment of neuroectodermal tumors
07/19/2012US20120183543 Diagnostic biomarkers for fibrotic disorders
07/19/2012US20120183542 Treating neurological disorders
07/19/2012US20120183541 Hair growth methods using fgfr4 extracellular domains
07/19/2012US20120183540 Methods of promoting fat loss comprising administering an alk7 inhibitor
07/19/2012US20120183539 Cancer Metastasis Inhibitor
07/19/2012US20120183538 Sparc antisense compositions and uses thereof
1 ... 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 ... 1823